Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort - Sorbonne Université Access content directly
Journal Articles Metabolism Year : 2023

Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort

Bénédicte Gaborit
  • Function : Author
Sara Fernandes
  • Function : Author
Paul Loubet
  • Function : Author
Laetitia Ninove
  • Function : Author
Anne Dutour
  • Function : Author
Bertrand Cariou
  • Function : Author
Muriel Coupaye
  • Function : Author
Sébastien Czernichow
  • Function : Author
Claire Carette
  • Function : Author
Noémie Resseguier
  • Function : Author
Laure Esterle
  • Function : Author
Sabrina Kali
  • Function : Author
Marie Houssays
  • Function : Author
Xavier de Lamballerie
  • Function : Author
Linda Wittkop
  • Function : Author
Odile Launay
  • Function : Author
Martine Laville
  • Function : Author
No file

Dates and versions

hal-04153541 , version 1 (06-07-2023)

Identifiers

Cite

Bénédicte Gaborit, Sara Fernandes, Paul Loubet, Laetitia Ninove, Anne Dutour, et al.. Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort. Metabolism, 2023, 142 (7), pp.155412. ⟨10.1016/j.metabol.2023.155412⟩. ⟨hal-04153541⟩
1 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More